Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data.
Roope KalskeAliasghar A KiadaliriRaine SihvonenMartin EnglundAleksandra TurkiewiczMika PaavolaAntti MalmivaaraAri ItäläAntti JoukainenHeikki NurmiPirjo ToivonenSimo TaimelaTeppo L N Järvinennull nullPublished in: Clinical orthopaedics and related research (2024)
The results of this study lend further support to clinical practice guidelines recommending against the use of APM in patients with a degenerative meniscus tear. Given the robustness of existing evidence demonstrating no benefit or cost effectiveness of APM over nonsurgical treatment or placebo surgery, future research is unlikely to alter this conclusion.Level of Evidence Level III, economic analysis.
Keyphrases
- minimally invasive
- phase iii
- coronary artery bypass
- anterior cruciate ligament reconstruction
- surgical site infection
- clinical trial
- double blind
- study protocol
- electronic health record
- current status
- open label
- placebo controlled
- phase ii
- randomized controlled trial
- percutaneous coronary intervention
- acute coronary syndrome
- atrial fibrillation
- replacement therapy